Andrew Geller Ms

Andrew Geller MS, MB(ASCP) is an accomplished professional in the field of molecular diagnostics with significant experience in research and development. Currently serving as Vice President of Research and Development at Clinical Enterprise, Andrew Geller has led the innovation and strategic development of numerous molecular tests, overseeing major projects such as single cell RNA sequencing and NGS-based proteomics. Previous roles include Director of Research and Development, where Andrew Geller provided scientific leadership and successfully launched new molecular tests, including a RT-PCR assay for SARS-CoV-2. Their educational background includes a Master of Science in Biochemical and Molecular Nutrition from The Friedman School of Nutrition Science and Policy at Tufts University and a Bachelor of Science in Biology from Union College.